mounjaro tirzepatide injection (tirzepatide) for the Treatment of Type 2 Diabetes, USA Mounjaro® (tirzepatide) injection and Zepbound®

A one-time intake and consent form must be completed before your first shot which takes less than five minutes and can be found here

The 12-month commitment may feel long, but its well-rated group-based approach helps many members succeed

To be eligible for Mounjaro, you must have: a BMI (body mass index) of 30kg/m or over (obese) a BMI between 27 and 30kg/m (overweight), and a weight-related health condition such as high cholesterol, high blood pressure, pre-diabetes or heart problems a BMI of 27.5kg/m and a higher risk ethnic background (South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean) You should let your prescriber know about any health problems you have and any medications you take so they can check Mounjaro is suitable for you

AASLD 2020 Nov 11-16 Anne Flint1, Grit Andersen2, Paul Hockings3, Lars Johansson3, Anni Morsing1, Mads Sundby Palle1, Thomas J Vogl4 and Leona Plum-Moerschel2, (1)Novo Nordisk a/S, (2)Profil, (3) Antaros Medical, (4)Goethe-Universitat Frankfurt Background: Non-alcoholic fatty liver disease (NAFLD) is thought to be the liver manifestation of metabolic syndrome